Gene · 4144
Papers1,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Curcumol induces autophagy-dependent hepatic stellate cell death through methionine metabolism disruption. | Toxicol Appl Pharmacol | 2026 | 42107543 | PubTator, text mining | PubMed |
| Targeting purinergic signaling and MTAP-associated metabolism in cancer: A functional immunometabolic convergence framework. | Biochem Pharmacol | 2026 | 42082122 | PubTator, text mining | PubMed |
| The Combination of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 and Recombinant Methioninase Is Not Cancer-selective in a Co-culture Model of Colon Cancer Cells and Normal Fibroblasts. | Cancer Diagn Progn | 2026 | 42078306 | PubTator, text mining | PubMed |
| Design and Discovery of Pyridazinone-Based MAT2A Inhibitors Targeting MTAP-Deficient Cancers. | J Med Chem | 2026 | 42024642 | PubTator, text mining | PubMed |
| Coordinated action of BSMT1, SABP3, and MAT2 activates methyl salicylate-mediated systemic immunity in plants. | Mol Plant | 2026 | 42001236 | PubTator, text mining | PubMed |
| Therapeutic vulnerabilities exposed by the 9p21 loss identified through multiparametric drug screening inform rational combination strategies. | NPJ Precis Oncol | 2026 | 42000949 | PubTator, text mining | PubMed |
| Novel Therapeutic Targets of Endothelial Inflammation in Acute Lung Injury and Acute Respiratory Distress Syndrome. | J Respir Biol Transl Med | 2026 | 41939174 | PubTator, text mining | PubMed |
| Protein arginine methyltransferases in cancer: mechanisms, functions, and therapeutic opportunities. | J Biomed Sci | 2026 | 41928257 | PubTator, text mining | PubMed |
| Real-World Prevalence and Structural Validation of the Canonical 9p21 MTAP-CDKN2A/B Deletion in Non-NSCLC Solid Tumors. | Cancers (Basel) | 2026 | 41899498 | PubTator, text mining | PubMed |
| MYH11 variants in thoracic aortic aneurysm pathophysiology: From bench to bedside. | Eur J Clin Invest | 2026 | 41891259 | PubTator, text mining | PubMed |
| Recent Advances in Targeted Therapies for Adult Gliomas. | Curr Neurol Neurosci Rep | 2026 | 41874881 | PubTator, text mining | PubMed |
| Coupled-enzyme assay for MTAP activity in biological samples. | Anal Biochem | 2026 | 41825704 | PubTator, text mining | PubMed |
| Metabolic reprogramming in cancer: dysregulation of glucose, lipid, and amino acid pathways and therapeutic opportunities. | Mol Biomed | 2026 | 41806079 | PubTator, text mining | PubMed |
| Targeting methionine-induced pyroptosis enhances anti-tumor immunity. | Sci China Life Sci | 2026 | 41793590 | PubTator, text mining | PubMed |
| Senescence-associated and immune-related 9p21.3 locus genes in colorectal cancer: epigenetic architecture, molecular landscape and therapeutic possibilities. | Front Cell Dev Biol | 2026 | 41756674 | PubTator, text mining | PubMed |
| Journey of Methionine Adenosyltransferase 2A Inhibitors: From Bench to Advanced Clinical Trials. | J Med Chem | 2026 | 41738461 | PubTator, text mining | PubMed |
| Unraveling the potential of targeting methionine metabolism in cancer. | Cancer Lett | 2026 | 41722835 | PubTator, text mining | PubMed |
| A small molecule inhibitor of ARF GTPase protein 1 limits liver and colon cancer cell growth and metastasis. | Cell Death Dis | 2026 | 41720764 | PubTator, text mining | PubMed |
| Methionine restriction in cancer: a dietary insight for therapy. | Front Nutr | 2026 | 41710278 | PubTator, text mining | PubMed |
| Cytoplasmic poly-adenosine binding proteins modulate susceptibility of mRNAs to Pumilio-mediated decay. | Nucleic Acids Res | 2026 | 41641701 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4144/papers?page=2